Opaleye Management Inc.'s Form 4 filing
Protara Therapeutics, Inc. (TARA) · filed Jul 3, 2024
- Accession no.
- 0001493152-24-026181
- Filed
- Jul 3, 2024
- Trade date
- Jul 1, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $17.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Opaleye Management Inc.CIK 0001595855 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2024 | Common Stock, par value $0.001 per share | SSaleDisposed | −5,788 | $2.12 | −$12,270.56 | 2,213,474 | Indirect | |
| Jul 1, 2024 | Common Stock, par value $0.001 per share | SSaleDisposed | −2,500 | $2.12 | −$5,300 | 87,500 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.